Soleno Therapeutics, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6 7 8 9 10 11 12
Rok finansowy 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 3 0 0 1 -1,553 0 0 0 0 0 0 0
Przychód Δ r/r 0.0% inf% -100.0% inf% 274.3% -107145.4% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Marża brutto 0.0% 100.0% 0.0% 9.0% -4.0% 100.0% 0.0% -inf% -inf% -inf% -inf% -inf% 0.0%
EBIT (mln) -4 -1 -5 -12 -14 -12 -14 -23 -36 -32 -24 -39 0
EBIT Δ r/r 0.0% -76.5% 509.3% 135.7% 11.9% -10.6% 17.5% 64.2% 54.5% -13.1% -22.6% 58.5% -100.0%
EBIT (%) 0.0% -28.2% 0.0% -3137.6% -938.1% 0.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Koszty finansowe (mln) 3 3 4 0 0 0 0 0 0 0 -0 0 -0
EBITDA (mln) -4 -1 -10 -15 -15 -5 -16 -16 -39 -32 -26 -37 0
EBITDA(%) 0.0% -26.8% 0.0% -3943.8% -1044.0% 0.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Podatek (mln) 3 3 -0 -0 0 -2 3 5 -9 -1 -4 0 0
Zysk Netto (mln) -6 -4 -14 -16 -12 -16 -13 -36 -15 -30 -20 -39 -176
Zysk netto Δ r/r 0.0% -42.8% 274.3% 14.7% -24.2% 29.9% -14.9% 169.3% -57.2% 92.3% -31.3% 91.9% 351.0%
Zysk netto (%) 0.0% -123.6% 0.0% -4104.8% -831.6% 1.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
EPS -346.98 -198.45 -819.38 -126.58 -58.35 -26.18 -9.54 -15.78 -3.68 -5.56 -2.42 -2.36 -4.38
EPS (rozwodnione) -346.98 -198.45 -819.38 -126.58 -58.35 -26.18 -9.54 -15.78 -3.68 -5.56 -2.42 -2.36 -4.38
Ilośc akcji (mln) 0 0 0 0 0 1 1 2 4 5 8 16 40
Ważona ilośc akcji (mln) 0 0 0 0 0 1 1 2 4 5 8 16 40
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD